caelyx - Janssen
... pharyngitis, rash, pruritus, sweating, injection site reaction and drug interaction. Very rarely, convulsions have been observed in relation to infusion reactions. Temporarily stopping the infusion usually resolves these symptoms without further therapy. However, medication to treat these symptoms ( ...
... pharyngitis, rash, pruritus, sweating, injection site reaction and drug interaction. Very rarely, convulsions have been observed in relation to infusion reactions. Temporarily stopping the infusion usually resolves these symptoms without further therapy. However, medication to treat these symptoms ( ...
NSTEMI standing orders
... JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidel ...
... JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidel ...
Doripenem (Doribax): the newest addition to the
... MICs are raised, and resistance is conferred. Similar to alterations in the OprD porin, alterations in the efflux pumps alone do not normally confer high-level carbapenem resistance. Sakyo and colleagues conducted a study to evaluate the potency of carbapenems for the prevention of carbapenem-resist ...
... MICs are raised, and resistance is conferred. Similar to alterations in the OprD porin, alterations in the efflux pumps alone do not normally confer high-level carbapenem resistance. Sakyo and colleagues conducted a study to evaluate the potency of carbapenems for the prevention of carbapenem-resist ...
SUMMARY OF DATA FOR CHEMICAL SELECTION
... Source Naturals Vincamine, a widely distributed vincamine supplement, is composed of 20 mg tablets with a recommended dosage of one tablet three times a day (iHerb, Inc., 2002). Because of vincamine’s very short elimination half-life, sustained release forms are also used (EMEA, 1999). An example is ...
... Source Naturals Vincamine, a widely distributed vincamine supplement, is composed of 20 mg tablets with a recommended dosage of one tablet three times a day (iHerb, Inc., 2002). Because of vincamine’s very short elimination half-life, sustained release forms are also used (EMEA, 1999). An example is ...
Caspofungin: the first agent available in the echinocandin class of
... concentrations. Results in a small number of patients receiving efavirenz, nalfinavir, nevirapine, phenytoin, rifampin, dexamethasone, or carbamazepine prior to and/or concurrent with caspofungin indicate that an increase in the maintenance dose from 50 mg to 70 mg daily (after a 70-mg loading dose) ...
... concentrations. Results in a small number of patients receiving efavirenz, nalfinavir, nevirapine, phenytoin, rifampin, dexamethasone, or carbamazepine prior to and/or concurrent with caspofungin indicate that an increase in the maintenance dose from 50 mg to 70 mg daily (after a 70-mg loading dose) ...
"פורמט עלון זה נקבע ע"י משרד הבריאות ותוכנו נבדק ואושר"
... Hepatic toxicity: Chronic hepatitis, as evidenced by elevations of hepatic enzymes and bilirubin have been reported during use of papaverine. Most of the affected patients were also consuming alcohol and a causal relationship to papaverine has not been proven. Routine monitoring of hepatic function ...
... Hepatic toxicity: Chronic hepatitis, as evidenced by elevations of hepatic enzymes and bilirubin have been reported during use of papaverine. Most of the affected patients were also consuming alcohol and a causal relationship to papaverine has not been proven. Routine monitoring of hepatic function ...
CONCERTA Extended-Release Tablets PRODUCT INFORMATION
... might be compromised by increases in blood pressure or heart rate. Blood pressure and cardiovascular status should be reviewed regularly during treatment with CONCERTA. ...
... might be compromised by increases in blood pressure or heart rate. Blood pressure and cardiovascular status should be reviewed regularly during treatment with CONCERTA. ...
What is an optimal dosage regimen - Physiologie et Thérapeutique
... The inoculum effect and Very Early Treatment (VET) • Efficacious dosage regimen is different when the pathogen load is large, low or null • Treatment should start as early as possible ...
... The inoculum effect and Very Early Treatment (VET) • Efficacious dosage regimen is different when the pathogen load is large, low or null • Treatment should start as early as possible ...
1.3.1.1 Summary of Product Characteristics
... Undesirable effects reported by the investigators as possibly, probably or definitely related to the drug are presented below if they occurred in 1 % of any in the treatment groups in the one-year study or in 1 % of the patients who were treated with alendronate 10 mg per day and with an inciden ...
... Undesirable effects reported by the investigators as possibly, probably or definitely related to the drug are presented below if they occurred in 1 % of any in the treatment groups in the one-year study or in 1 % of the patients who were treated with alendronate 10 mg per day and with an inciden ...
Full Prescribing Information
... • BELBUCA exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient’s risk before prescribing, and monitor regularly for these behaviors and conditions. (5.1, 10) • Serious, life-threatening, or fatal respiratory depression may occur. Monitor cl ...
... • BELBUCA exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient’s risk before prescribing, and monitor regularly for these behaviors and conditions. (5.1, 10) • Serious, life-threatening, or fatal respiratory depression may occur. Monitor cl ...
Levodopa
... norepinephrine and serotonin) unless given at above recommended doses, where it loses its selectivity. By, thus, decreasing the metabolism of dopamine, selegiline has been found to increase dopamine levels in the brain. Therefore, it enhances the actions of levodopa when these drugs are administere ...
... norepinephrine and serotonin) unless given at above recommended doses, where it loses its selectivity. By, thus, decreasing the metabolism of dopamine, selegiline has been found to increase dopamine levels in the brain. Therefore, it enhances the actions of levodopa when these drugs are administere ...
1 ——— INDICATIONS AND USAGE ——— Saxenda® is a
... 2 (0.1%) of 1843 placebo-treated patients. In addition, there were 2 cases of acute pancreatitis in Saxenda® -treated patients who prematurely withdrew from these clinical trials, occurring 74 and 124 days after the last dose. There were 2 additional cases in Saxenda® -treated patients, 1 during an ...
... 2 (0.1%) of 1843 placebo-treated patients. In addition, there were 2 cases of acute pancreatitis in Saxenda® -treated patients who prematurely withdrew from these clinical trials, occurring 74 and 124 days after the last dose. There were 2 additional cases in Saxenda® -treated patients, 1 during an ...
[Product Monograph Template
... Anaphylactoid Reactions during LDL Apheresis: Rarely, patients receiving ACE inhibitors during low-density lipoprotein (LDL)-apheresis with dextran sulfate have experienced life- threatening anaphylactoid reactions. These reactions were avoided by temporarily withholding ACE inhibitor therapy prior ...
... Anaphylactoid Reactions during LDL Apheresis: Rarely, patients receiving ACE inhibitors during low-density lipoprotein (LDL)-apheresis with dextran sulfate have experienced life- threatening anaphylactoid reactions. These reactions were avoided by temporarily withholding ACE inhibitor therapy prior ...
Seretide Accuhaler
... pre-existing cardiovascular disease. A transient decrease in serum potassium may occur with all sympathomimetic drugs at higher therapeutic doses. Therefore, Seretide should be used with caution in patients predisposed to low levels of serum potassium. Systemic effects may occur with any inhaled cor ...
... pre-existing cardiovascular disease. A transient decrease in serum potassium may occur with all sympathomimetic drugs at higher therapeutic doses. Therefore, Seretide should be used with caution in patients predisposed to low levels of serum potassium. Systemic effects may occur with any inhaled cor ...
Lansoprazole/C02-039 A Phase 2, Open-Label Multicenter
... Some clinical studies may include information not contained in the approved package insert. Please refer to the full prescribing information for additional information. Because the status of studies often changes, TAP makes no warranties or representations of any kind as to the current status or co ...
... Some clinical studies may include information not contained in the approved package insert. Please refer to the full prescribing information for additional information. Because the status of studies often changes, TAP makes no warranties or representations of any kind as to the current status or co ...
PrZELBORAF®
... QT Prolongation In both Phase II and Phase III studies, patients were excluded if they had a baseline QTc interval of ≥450 msec. Exposure-dependent QTc prolongation was observed in an uncontrolled, open-label Phase II QT sub-study in previously treated patients with metastatic melanoma. Analysis of ...
... QT Prolongation In both Phase II and Phase III studies, patients were excluded if they had a baseline QTc interval of ≥450 msec. Exposure-dependent QTc prolongation was observed in an uncontrolled, open-label Phase II QT sub-study in previously treated patients with metastatic melanoma. Analysis of ...
MELOXICAM Veterinary—Systemic
... on the basis of their potential clinical significance (reasons given in parentheses where appropriate)—not necessarily inclusive (» = major clinical significance). Except under special circumstances, this medication should not be used when the following medical problems exist: Bleeding disorders{R-3 ...
... on the basis of their potential clinical significance (reasons given in parentheses where appropriate)—not necessarily inclusive (» = major clinical significance). Except under special circumstances, this medication should not be used when the following medical problems exist: Bleeding disorders{R-3 ...
Potential Part D Drug-Drug Interactions
... Voriconazole has the potential for QT interval prolongation and rare occurrences of torsades de pointes. Macrolide antibiotics may increase plasma concentrations and pharmacologic effects of pimozide oral. Additive cardiotoxicity may occur when pimozide oral and macrolides are co-administered; conco ...
... Voriconazole has the potential for QT interval prolongation and rare occurrences of torsades de pointes. Macrolide antibiotics may increase plasma concentrations and pharmacologic effects of pimozide oral. Additive cardiotoxicity may occur when pimozide oral and macrolides are co-administered; conco ...
A fatal outcome after unintentional overdosing of rivastigmine patches
... The report described an 87-year old male with dementia. The patient was treated with rivastigmine patches (Exelon 9,5 mg/24 h, q.d.), dimethicone (200 mg t.i.d.), acetylsalicylic acid (75 mg q.d.), etilefrine (5 mg t.i.d.), alprazolam (0,5 mg q.d.), escitalopram (20 mg q.d.) and mirtazapine (15 mg q ...
... The report described an 87-year old male with dementia. The patient was treated with rivastigmine patches (Exelon 9,5 mg/24 h, q.d.), dimethicone (200 mg t.i.d.), acetylsalicylic acid (75 mg q.d.), etilefrine (5 mg t.i.d.), alprazolam (0,5 mg q.d.), escitalopram (20 mg q.d.) and mirtazapine (15 mg q ...
Femara - Novartis
... = 4.4%) (P<0.0001). No patients with a normal BMD at baseline became osteoporotic over the 2 years and only 1 patient with osteopenia at baseline (T score of -1.9) developed osteoporosis during the treatment period (assessment by central review). The results for total hip BMD were similar, although ...
... = 4.4%) (P<0.0001). No patients with a normal BMD at baseline became osteoporotic over the 2 years and only 1 patient with osteopenia at baseline (T score of -1.9) developed osteoporosis during the treatment period (assessment by central review). The results for total hip BMD were similar, although ...
... Various studies provide evidence that equianalgesic doses of pethidine cause similar effects on the sphincter of Oddi and the biliary tract to other opioids. All opioids have been found to increase biliary tract pressure 1, which may result in spasm of the sphincter of Oddi, leading to epigastric di ...
Zolpidem Mylan film-coated tablet ENG SmPC
... product should be discontinued. These reactions are more likely to occur in the elderly. Somnambulism and associated behaviours Sleep walking and other associated behaviours such as “sleep driving”, preparing and eating food, making phone calls or having sex, with amnesia for the event, have been re ...
... product should be discontinued. These reactions are more likely to occur in the elderly. Somnambulism and associated behaviours Sleep walking and other associated behaviours such as “sleep driving”, preparing and eating food, making phone calls or having sex, with amnesia for the event, have been re ...
MS_Word ~ KB
... Various studies provide evidence that equianalgesic doses of pethidine cause similar effects on the sphincter of Oddi and the biliary tract to other opioids. All opioids have been found to increase biliary tract pressure 1, which may result in spasm of the sphincter of Oddi, leading to epigastric di ...
... Various studies provide evidence that equianalgesic doses of pethidine cause similar effects on the sphincter of Oddi and the biliary tract to other opioids. All opioids have been found to increase biliary tract pressure 1, which may result in spasm of the sphincter of Oddi, leading to epigastric di ...
MS_Word ~ 131 KB
... Resting intrabiliary pressure, perfusion pain level and pressure changes have been measured postoperatively utilising T-tube drainage of the bile duct in the presence of pethidine 100 mg IM, codeine 60 mg SC and morphine 10 mg SC .3 Codeine caused the least spasm of the sphincter of Oddi, followed b ...
... Resting intrabiliary pressure, perfusion pain level and pressure changes have been measured postoperatively utilising T-tube drainage of the bile duct in the presence of pethidine 100 mg IM, codeine 60 mg SC and morphine 10 mg SC .3 Codeine caused the least spasm of the sphincter of Oddi, followed b ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.